NF-κB-IN-9

NF-κB-IN-9 is a sonosensitizer with λex/λem of 489/628 nm, featuring dual resveratrol units that potently inhibit NF-κB signaling. It exhibits significant anti-tumor activity and sonocytotoxicity in vitro, while demonstrating biosafety in in vivo xenograft mouse models, supporting research in sonodynamic therapy and cancer signaling pathways.